Drugs / Asmanex Twisthaler
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | ASMANEX TWISTHALER | — | 2008-02-01 | fda.gov ↗ |
| Approved | US (FDA) | ASMANEX TWISTHALER | — | 2005-03-30 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00442351 | Sep 2006 → Apr 2007 | asthma | Organon and Co | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Asmanex Twisthaler | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00442351 ↗ |
| Route | Inhaled | “Mometasone furoate inhalation powder” NCT00442351 ↗ |